Found: 20
Select item for more details and to access through your institution.
Nerve Fibers in the Tumor Microenvironment Are Co-Localized with Lymphoid Aggregates in Pancreatic Cancer.
- Published in:
- Journal of Clinical Medicine, 2021, v. 10, n. 3, p. 490, doi. 10.3390/jcm10030490
- By:
- Publication type:
- Article
The COVID-19 Pandemic Is Associated with Reduced Survival after Pancreatic Ductal Adenocarcinoma Diagnosis: A Single-Centre Retrospective Analysis.
- Published in:
- Journal of Clinical Medicine, 2022, v. 11, n. 9, p. 2574, doi. 10.3390/jcm11092574
- By:
- Publication type:
- Article
Advances in Immunotherapeutics in Pancreatic Ductal Adenocarcinoma.
- Published in:
- Cancers, 2023, v. 15, n. 17, p. 4265, doi. 10.3390/cancers15174265
- By:
- Publication type:
- Article
The Presence of Small Nerve Fibers in the Tumor Microenvironment as Predictive Biomarker of Oncological Outcome Following Partial Hepatectomy for Intrahepatic Cholangiocarcinoma.
- Published in:
- Cancers, 2021, v. 13, n. 15, p. 3661, doi. 10.3390/cancers13153661
- By:
- Publication type:
- Article
Activated Regulatory T-Cells, Dysfunctional and Senescent T-Cells Hinder the Immunity in Pancreatic Cancer.
- Published in:
- Cancers, 2021, v. 13, n. 8, p. 1776, doi. 10.3390/cancers13081776
- By:
- Publication type:
- Article
Circulating Cell-Free Tumour DNA for Early Detection of Pancreatic Cancer.
- Published in:
- Cancers, 2020, v. 12, n. 12, p. 3704, doi. 10.3390/cancers12123704
- By:
- Publication type:
- Article
Clinical trial protocol for PanDox: a phase I study of targeted chemotherapy delivery to non-resectable primary pancreatic tumours using thermosensitive liposomal doxorubicin (ThermoDox®) and focused ultrasound.
- Published in:
- BMC Cancer, 2023, v. 23, n. 1, p. 1, doi. 10.1186/s12885-023-11228-z
- By:
- Publication type:
- Article
Nerve Fibers in the Tumor Microenvironment as a Novel Biomarker for Oncological Outcome in Patients Undergoing Surgery for Perihilar Cholangiocarcinoma.
- Published in:
- Liver Cancer (2235-1795), 2021, v. 10, n. 3, p. 260, doi. 10.1159/000515303
- By:
- Publication type:
- Article
ToxNav germline genetic testing and PROMinet digital mobile application toxicity monitoring: Results of a prospective single‐center clinical utility study—PRECISE study.
- Published in:
- Cancer Medicine, 2019, v. 8, n. 14, p. 6305, doi. 10.1002/cam4.2529
- By:
- Publication type:
- Article
Improving early diagnosis of pancreatic cancer in symptomatic patients.
- Published in:
- British Journal of General Practice, 2023, v. 73, n. 737, p. 534, doi. 10.3399/bjgp23x735585
- By:
- Publication type:
- Article
Immunophenotypes of pancreatic ductal adenocarcinoma: Meta‐analysis of transcriptional subtypes.
- Published in:
- International Journal of Cancer, 2019, v. 145, n. 4, p. 1125, doi. 10.1002/ijc.32186
- By:
- Publication type:
- Article
Unlocking the diagnostic power of plasma extracellular vesicle miR-200 family in pancreatic ductal adenocarcinoma.
- Published in:
- Journal of Experimental & Clinical Cancer Research (17569966), 2024, v. 43, n. 1, p. 1, doi. 10.1186/s13046-024-03090-z
- By:
- Publication type:
- Article
Predicting the risk of pancreatic cancer in adults with new-onset diabetes: development and internal–external validation of a clinical risk prediction model.
- Published in:
- British Journal of Cancer, 2024, v. 130, n. 12, p. 1969, doi. 10.1038/s41416-024-02693-9
- By:
- Publication type:
- Article
Biomarkers of response to PD-1 pathway blockade.
- Published in:
- British Journal of Cancer, 2022, v. 126, n. 12, p. 1663, doi. 10.1038/s41416-022-01743-4
- By:
- Publication type:
- Article
Biomarkers of response to PD-1 pathway blockade.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Expression of Checkpoint Molecules in the Tumor Microenvironment of Intrahepatic Cholangiocarcinoma: Implications for Immune Checkpoint Blockade Therapy.
- Published in:
- Cells (2073-4409), 2023, v. 12, n. 6, p. 851, doi. 10.3390/cells12060851
- By:
- Publication type:
- Article
Master Regulators of Oncogenic KRAS Response in Pancreatic Cancer: An Integrative Network Biology Analysis.
- Published in:
- 2017
- By:
- Publication type:
- journal article
A bile-based microRNA signature for differentiating malignant from benign pancreaticobiliary disease.
- Published in:
- Experimental Hematology & Oncology, 2023, v. 12, n. 1, p. 1, doi. 10.1186/s40164-023-00458-3
- By:
- Publication type:
- Article
Manipulating regulatory T cells: is it the key to unlocking effective immunotherapy for pancreatic ductal adenocarcinoma?
- Published in:
- Frontiers in Immunology, 2024, p. 1, doi. 10.3389/fimmu.2024.1406250
- By:
- Publication type:
- Article
Bile Microbiome Signatures Associated with Pancreatic Ductal Adenocarcinoma Compared to Benign Disease: A UK Pilot Study.
- Published in:
- International Journal of Molecular Sciences, 2023, v. 24, n. 23, p. 16888, doi. 10.3390/ijms242316888
- By:
- Publication type:
- Article